Clinical Trial Update: A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

A cross-over study of OligoG in subjects with cystic fibrosis has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• OligoG (oligoG)

Snippet

Sponsor: AlgiPharma AS | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED